How many insider trades does FilingIQ track for TELA?

FilingIQ tracks 424 Form 4 insider transactions for TELA (TELA Bio, Inc.), covering filings from Nov 13, 2019 onwards. 9 of those are dated within the last 90 days.

Are TELA insiders net buyers or net sellers?

Across the full Form 4 history for TELA, 245 transactions (58%) were open-market purchases and 7 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TELA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is TELA in?

TELA Bio, Inc. (TELA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $30.74M.

TELA insider trading

NasdaqGM Healthcare

TELA Bio, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

424

Last 90 days

Buys / sells

58% / 2%

Market cap

$30.74M

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Company website: www.telabio.com

TELA insider activity at a glance

FilingIQ tracks 424 insider transactions for TELA in filings since Nov 13, 2019. The most recent transaction is dated Sep 17, 2026.

Across the full history, 245 open-market purchases and 7 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TELA insider trades is 40.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TELA trades on FilingIQ Raw filings on SEC EDGAR

Latest TELA Form 4 filings

Getz Heather C Chief Executive Officer

P Aug 19, 2026

Getz Heather C Chief Executive Officer

P Aug 17, 2026

Getz Heather C Chief Executive Officer

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for TELA?: FilingIQ tracks 424 Form 4 insider transactions for TELA (TELA Bio, Inc.), covering filings from Nov 13, 2019 onwards. 9 of those are dated within the last 90 days.
Are TELA insiders net buyers or net sellers?: Across the full Form 4 history for TELA, 245 transactions (58%) were open-market purchases and 7 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TELA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is TELA in?: TELA Bio, Inc. (TELA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $30.74M.

Methodology & sources

Every TELA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.